These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 2826741

  • 1. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ, Hamid Q, Ibrahim NB, Fahey M, Bloom SR, Polak JM.
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [Abstract] [Full Text] [Related]

  • 2. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
    Springall DR, Ibrahim NB, Rode J, Sharpe MS, Bloom SR, Polak JM.
    J Pathol; 1986 Nov; 150(3):151-62. PubMed ID: 3027289
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN, Corrin B, Bennett MH, Marangos PJ, Bloom SR, Polak JM.
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [Abstract] [Full Text] [Related]

  • 4. Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma.
    Hamid QA, Addis BJ, Springall DR, Ibrahim NB, Ghatei MA, Bloom SR, Polak JM.
    Virchows Arch A Pathol Anat Histopathol; 1987 Mar; 411(2):185-92. PubMed ID: 3037770
    [Abstract] [Full Text] [Related]

  • 5. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A, Zabel M, Biczysko W.
    Pol J Pathol; 2007 Mar; 58(1):23-33. PubMed ID: 17585539
    [Abstract] [Full Text] [Related]

  • 6. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
    Said JW, Vimadalal S, Nash G, Shintaku IP, Heusser RC, Sassoon AF, Lloyd RV.
    Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
    [Abstract] [Full Text] [Related]

  • 7. Gastrin releasing peptide in human neuroendocrine tumours.
    Bostwick DG, Bensch KG.
    J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
    [Abstract] [Full Text] [Related]

  • 8. Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.
    Suresh UR, Wilkes S, Hasleton PS.
    J Clin Pathol; 1991 Jul; 44(7):573-5. PubMed ID: 1713221
    [Abstract] [Full Text] [Related]

  • 9. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
    Ling C, Shen Y.
    J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
    [Abstract] [Full Text] [Related]

  • 10. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P, Malamou-Mitsi V, Martinopoulou U, Legaki S, Tamvakis N, Vrettou E, Fountzilas G, Skarlos D, Kosmidis P, Pavlidis N.
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [Abstract] [Full Text] [Related]

  • 11. Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors.
    Bostwick DG, Roth KA, Evans CJ, Barchas JD, Bensch KG.
    Am J Pathol; 1984 Nov; 117(2):195-200. PubMed ID: 6093543
    [Abstract] [Full Text] [Related]

  • 12. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
    Mayall FG, Gibbs AR.
    J Pathol; 1991 May; 164(1):47-50. PubMed ID: 1647450
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody 123C3 in lung tumour classification. Immunohistology of 358 resected lung tumours.
    Mooi WJ, Wagenaar SS, Schol D, Hilgers J.
    Mol Cell Probes; 1988 Mar; 2(1):31-7. PubMed ID: 2837665
    [Abstract] [Full Text] [Related]

  • 14. S-100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature.
    Barbareschi M, Mauri MF, Muscara M, Mauri FA, Lo Re V.
    Histol Histopathol; 1987 Apr; 2(2):185-92. PubMed ID: 2856552
    [Abstract] [Full Text] [Related]

  • 15. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D, Yesner R.
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [Abstract] [Full Text] [Related]

  • 16. Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
    Leader M, Collins M, Patel J, Henry K.
    J Clin Pathol; 1986 Nov; 39(11):1186-92. PubMed ID: 3540015
    [Abstract] [Full Text] [Related]

  • 17. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, Dabbs DD, Raab SS, Silverman JF.
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG, Johnston CF, Sloan JM, Buchanan KD.
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [Abstract] [Full Text] [Related]

  • 20. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K.
    Anticancer Res; 1999 Mar; 19(4A):2673-8. PubMed ID: 10470218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.